Profile data is unavailable for this security.
About the company
Beijing Biostar Pharmaceuticals Co Ltd is a Chinea-based company principally engaged in the research, development, production and sales of innovative drugs. The Company's products and pipeline mainly include Utidelone Injection, Utidelone Capsule, Utidelone Nanoformulation, Utidelone Antibody Drug Conjugate (ADC), BG22, BG18 and BG44. The Company's products are principally used for the treatment of relapsed or metastatic breast cancer, neoadjuvant treatment of human epidermal growth factor receptor 2 (HER2)-breast cancer neoadjuvant, advanced non-small cell lung cancer (NSCLC), solid tumors, breast cancer brain metastasis, lung cancer brain metastasis and other brain tumor indications. The Company mainly conducts its businesses in the domestic market.
- Revenue in HKD (TTM)--
- Net income in HKD--
- Incorporated2002
- Employees--
- LocationBeijing Biostar Pharmaceuticals Co LtdBEIJING 101111ChinaCHN
- Phone+86 1 067864938
- Fax+86 1 056315388
- Websitehttps://www.biostar-pharm.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tong Ren Tang Technologies Co Ltd | 7.51bn | 710.69m | 6.65bn | 4.01k | 9.35 | 0.8579 | 4.67 | 0.8851 | 0.5549 | 0.5549 | 5.86 | 6.05 | 0.5026 | 0.9881 | 5.22 | 1,831,283.00 | 7.42 | 7.68 | 11.69 | 12.32 | 40.97 | 43.50 | 14.76 | 16.11 | 2.30 | -- | 0.1968 | 39.94 | 13.04 | 6.01 | 1.25 | -2.73 | -22.26 | -0.0089 |
| Sihuan Pharmaceutical Holdings Group Ltd | 1.92bn | -41.28m | 6.71bn | 2.65k | -- | 1.39 | -- | 3.50 | -0.0044 | -0.0044 | 0.2065 | 0.518 | 0.1506 | 0.894 | 3.90 | 667,135.30 | -1.77 | -6.85 | -2.68 | -9.10 | 65.91 | 75.81 | -11.78 | -36.23 | 1.50 | -- | 0.181 | -- | -14.70 | -8.60 | 97.23 | -- | 0.9325 | -- |
| Beijing Tong Ren Tang Chinese Medicine | 1.38bn | 494.14m | 6.96bn | 779.00 | 14.09 | 1.83 | 11.26 | 5.06 | 0.5903 | 0.5903 | 1.64 | 4.55 | 0.3284 | 0.3554 | 3.62 | 1,725,133.00 | 12.72 | 16.71 | 14.09 | 18.75 | 72.06 | 69.88 | 38.72 | 40.72 | 9.55 | -- | 0.0327 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
| Consun Pharmaceutical Group Ltd | 2.99bn | 913.39m | 7.29bn | 3.18k | 7.61 | 1.80 | 7.29 | 2.44 | 1.13 | 1.13 | 3.71 | 4.79 | 0.5209 | 2.00 | 12.89 | 956,531.10 | 15.97 | 12.04 | 23.24 | 19.25 | 74.22 | 74.55 | 30.66 | 24.89 | 2.80 | -- | 0.1144 | 40.84 | 10.71 | 7.03 | 14.88 | 11.01 | -22.93 | 18.43 |
| China Shineway Pharmaceutical Group Ltd | 4.59bn | 1.21bn | 7.63bn | 3.23k | 5.78 | 0.9528 | 5.48 | 1.66 | 1.60 | 1.60 | 6.08 | 9.69 | 0.4476 | 1.28 | 5.26 | 1,336,300.00 | 11.76 | 8.03 | 15.47 | 9.77 | 75.21 | 74.55 | 26.27 | 17.87 | 3.14 | -- | 0.0457 | 36.29 | 14.32 | 11.94 | 34.14 | 13.89 | 0.6396 | 12.88 |
| Yichang Hec Changjiang Pharmactcl Co Ltd | 6.05bn | 1.80bn | 7.94bn | 4.89k | 4.41 | 0.8388 | 3.80 | 1.31 | 2.04 | 2.04 | 6.88 | 10.75 | 0.4272 | 2.50 | 3.74 | 1,310,148.00 | 11.69 | 8.03 | 17.27 | 11.81 | 78.90 | 79.97 | 27.37 | 20.80 | 1.93 | 50.79 | 0.2126 | 15.81 | 68.08 | 20.18 | 2,501.24 | 16.15 | -11.50 | -- |
| Beijing Biostar Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 9.52bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 103.03 | -- | -18.15 | -- | -- | -- |
| Everest Medicines Ltd | 457.08m | -1.15bn | 10.09bn | 520.00 | -- | 2.06 | -- | 22.07 | -3.57 | -3.57 | 1.42 | 15.02 | 0.0756 | 5.23 | 3.22 | 1,058,047.00 | -19.03 | -30.52 | -20.21 | -33.14 | 75.74 | -- | -251.64 | -5,745.25 | 4.62 | -- | 0.1119 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
| AIM Vaccine Co Ltd | 1.29bn | -1.30bn | 10.12bn | 1.56k | -- | 2.65 | -- | 7.83 | -1.07 | -1.07 | 1.07 | 3.16 | 0.1462 | 0.6325 | 1.10 | 796,283.20 | -22.69 | -- | -37.16 | -- | 72.34 | -- | -155.22 | -- | 0.6836 | -6.61 | 0.3437 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
| Luye Pharma Group Ltd | 6.89bn | 841.38m | 10.65bn | 5.23k | 12.65 | 0.7488 | 6.29 | 1.54 | 0.2237 | 0.2237 | 1.83 | 3.78 | 0.236 | 2.44 | 3.02 | 1,308,279.00 | 3.11 | 2.80 | 5.47 | 4.45 | 68.73 | 70.53 | 13.18 | 10.39 | 1.20 | 3.14 | 0.4103 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
| SSY Group Ltd | 6.47bn | 1.37bn | 11.24bn | 5.80k | 8.27 | 1.56 | 6.15 | 1.74 | 0.4593 | 0.4593 | 2.18 | 2.44 | 0.5418 | 2.75 | 3.07 | 1,155,141.00 | 11.54 | 10.51 | 14.88 | 14.03 | 54.39 | 58.72 | 21.30 | 18.62 | 2.06 | 28.65 | 0.323 | 38.56 | 0.4505 | 9.10 | 17.44 | 7.66 | 3.94 | 13.56 |
| Shanghai Henlius Biotech Inc | 6.16bn | 756.06m | 11.90bn | 3.55k | 15.78 | 4.23 | 10.27 | 1.93 | 1.39 | 1.39 | 11.28 | 5.18 | 0.5764 | 1.90 | 6.82 | 1,693,617.00 | 7.07 | -8.59 | 14.25 | -14.14 | 73.23 | 71.77 | 12.27 | -27.37 | 0.329 | 7.60 | 0.6113 | -- | 67.82 | 273.51 | 178.53 | -- | 49.14 | -- |
| China Traditional Chinese Med Hldg CoLtd | 18.79bn | 1.00bn | 12.09bn | 17.72k | 12.06 | 0.5179 | 5.29 | 0.6433 | 0.199 | 0.199 | 3.73 | 4.63 | 0.453 | 1.54 | 1.82 | 1,085,813.00 | 2.62 | 4.60 | 4.01 | 7.07 | 49.86 | 57.07 | 5.77 | 9.77 | 1.51 | 7.39 | 0.1808 | 17.35 | 26.69 | 9.99 | 68.11 | -2.24 | -12.75 | -- |
Data as of Nov 01 2024. Currency figures normalised to Beijing Biostar Pharmaceuticals Co Ltd's reporting currency: Hong Kong Dollar HKD
